Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Ketoconazole cream effectively treats fungal skin infections in cats.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.